Neurocrine Biosciences | Bénéfice Avant Impôts



Pre Tax Profit Changement Date
AbbVie USD 1.66B 3.15B 2025-03
Acadia Pharmaceuticals USD 27.78M 133.31M 2025-03
Agios Pharmaceuticals USD -89289000 16.11M 2025-03
ALKERMES USD 104.84M 79.35M 2025-06
Alnylam Pharmaceuticals USD -35358000 6.24M 2025-06
Amgen USD 3.38B 111M 2024-12
Biogen USD 744M 432.8M 2025-06
BioMarin Pharmaceutical USD 169.64M 35.2M 2024-12
Cytokinetics USD -161376000 11.36M 2025-03
Dynavax Technologies USD -97875000 105.5M 2025-03
Exelixis USD 230.42M 24.72M 2025-06
Gilead Sciences USD 2.96B 112M 2024-12
Halozyme Therapeutics USD 557.13M 359.8M 2024-12
Incyte USD 558.01M 323.82M 2025-06
Ionis Pharmaceuticals USD 124M 271M 2025-06
Neurocrine Biosciences USD 159.5M 144.8M 2025-06
Pfizer USD 4.44B 2.36B 2024-12
Prothena USD -59501000 335K 2024-12
Regeneron Pharmaceuticals USD 905M 53.1M 2025-03
Repligen USD 7.94M 46.55M 2025-03
Sarepta Therapeutics USD -383518000 555.26M 2025-03
Teva Pharmaceutical Industries USD 203M 91M 2025-06
Ultragenyx Pharmaceutical USD -133404000 191K 2024-12
Vertex Pharmaceuticals USD 1.32B 109.7M 2024-12


Neurocrine Biosciences Bénéfice Avant Impôts - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Aug 2025.